This is a news story, published by CNBC, that relates primarily to Oura news.
For more Oura news, you can click here:
more Oura newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from CNBC, you can click here:
more news from CNBCOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Eli Lilly researchers. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest muvalaplin news, high cholesterol news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
experimental pillCNBC
•
87% Informative
Eli Lilly's muvalaplin is designed to lower an inherited form of high cholesterol.
There are currently no approved treatments to lower Lp(a,) which can significantly increase the risk of heart attack, stroke and buildup of fatty plaques in the arteries.
About one in five Americans , or 63 million people, have elevated levels of LP(a, according to the Family Heart Foundation .
Dexcom and Oura are partnering with Oura in the metabolic health space.
Dexcom 's devices have historically been designed for patients with diabetes.
Oura announced in September that it has agreed to acquire Veri , a company that uses continuous glucose monitors to help users eat healthier and lose weight.
VR Score
87
Informative language
86
Neutral language
65
Article tone
formal
Language
English
Language complexity
57
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
4
Source diversity
4
Affiliate links
no affiliate links